Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
10 mars 2020 05h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with Novavax, Inc. (NASDAQ:NVAX) whereby Emergent...
Cytovance Biologics to Participate in RAFT Scientific Discussion on Commercialization of Fermentation Processes
18 oct. 2019 17h24 HE
|
Cytovance Biologics
OKLAHOMA CITY, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate...
Cadence Aerospace Names Vivian Martinez-Wells as Director, Business Development & Contracts, Cadence Aerospace–Aerosystems
26 nov. 2018 11h00 HE
|
Cadence Aerospace
ANAHEIM, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Cadence Aerospace, a provider of highly complex aerospace components and assemblies to commercial and defense customers, announces today the...
Cadence Aerospace Appoints Darren Waltier as Director, Business Development, Cadence Aerospace—Aerostructures
16 nov. 2018 13h00 HE
|
Cadence Aerospace
ANAHEIM, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Cadence Aerospace, a provider of highly complex aerospace components and assemblies to commercial and defense customers, announces today the...